Holen Sie sich die Stockscreener-App
30.21
1.69%
-0.52
Handel nachbörslich:
30.09
-0.12
-0.40%
Schlusskurs vom Vortag:
$30.73
Offen:
$30.6
24-Stunden-Volumen:
28,789
Relative Volume:
0.40
Marktkapitalisierung:
$119.45M
Einnahmen:
$36.84M
Nettoeinkommen (Verlust:
$-729.00K
KGV:
-32.71
EPS:
-0.9237
Netto-Cashflow:
$-10.02M
1W Leistung:
-5.00%
1M Leistung:
-10.91%
6M Leistung:
-21.12%
1J Leistung:
+32.45%
1-Tages-Spanne:
$29.79
$30.91
1-Wochen-Bereich:
$29.79
$32.38
52-Wochen-Spanne:
$19.50
$44.00
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Firmenname
Vtv Therapeutics Inc
Sektor
Branche
Telefon
336-841-0300
Adresse
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT vs VRTX, REGN, MRNA, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
30.21 | 119.45M | 36.84M | -729.00K | -10.02M | -0.9237 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Eingeleitet | Evercore ISI | Outperform |
| 2026-01-23 | Eingeleitet | Roth Capital | Buy |
| 2026-01-05 | Eingeleitet | TD Cowen | Buy |
| 2025-11-19 | Eingeleitet | BTIG Research | Buy |
| 2019-05-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-04-10 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-08 | Eingeleitet | Northland Capital | Outperform |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-09-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-24 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-08-24 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vtv Therapeutics Inc Aktie (VTVT) Neueste Nachrichten
Behavioral Patterns of VTVT and Institutional Flows - Stock Traders Daily
vTv Therapeutics (NASDAQ:VTVT) Stock Price Crosses Below 50 Day Moving AverageHere's What Happened - MarketBeat
vTv Therapeutics at H.C. Wainwright conference: CADI advances By Investing.com - Investing.com Australia
vTv Therapeutics at H.C. Wainwright conference: CADI advances - Investing.com
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
A new hire gets 2,500 options to buy vTv shares at $31.44 each - Stock Titan
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Raised to Hold at Zacks Research - marketbeat.com
vTv Therapeutics Q2 2026 Earnings: Net Loss Misses Consensus; No Revenue ReportedEarnings Outlook Update - careplusvn.com
vTv Therapeutics Inc (NASDAQ: VTVT) Share Price, VTVT Stock News, VTVT Share Price & Updates - Kalkine
Responsive Playbooks and the VTVT Inflection - news.stocktradersdaily.com
Lifesci Capital Upgrades vTv Therapeutics (NASDAQ:VTVT) to Strong-Buy - marketbeat.com
vTv Therapeutics (VTVT) Holds at $33.5 as Shares Consolidate Between Key Support and ResistanceSeasonality Effect - siam.in
vTv Therapeutics (VTVT) Holds Steady at $33.40 as Shares Trade FlatDiamond Pattern - vinanet.vn
Analysts Conflicted on These Healthcare Names: Kymera Therapeutics (KYMR) and vTv Therapeutics (VTVT) - The Globe and Mail
A type 1 diabetes drug developer plans two investor events in September - Stock Titan
vTv Therapeutics (NASDAQ:VTVT) Stock Price Passes Below 50-Day Moving AverageShould You Sell? - marketbeat.com
vTv Therapeutics to Participate in September Investor Conferences - GlobeNewswire
vTv Therapeutics Q2 2026 Earnings: Net Loss Slightly Wider Than Estimates, Shares Edge HigherPerformance Review - dars.gov.et
Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High? - qz.com
vTv (VTVT) Outlook: Finishes 0.53% Up at $33.26 in the Current Update; Technical View: Price Remains Between $31.60 Support and $34.92 Resistance on the DayBreakout Stock Alerts - dars.gov.et
vTv Therapeutics Inc. (NASDAQ:VTVT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
vTv Therapeutics (VTVT) Slips 2.37% to $30.12 as Support Holds in FocusDouble Top - vinanet.vn
The Technical Signals Behind (VTVT) That Institutions Follow - Stock Traders Daily
vTv Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
HC Wainwright Lowers Earnings Estimates for vTv Therapeutics - MarketBeat
vTv Therapeutics Inc (VTVT) Reports Q2 Loss of $1.05 Per Share -- What Does a GF Score of 26/100 Indicate? - GuruFocus
vTv Therapeutics Inc (VTVT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
vTv Therapeutics (NASDAQ:VTVT) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $42 - Moomoo
vTv Therapeutics Inc (VTVT) Stock News Today - TradingKey
vTv Therapeutics Inc expected to post a loss of $1.04 a shareEarnings Preview - TradingView
vTv Therapeutics (NASDAQ:VTVT) Posts Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat
vTv Therapeutics (VTVT) Advances Diabetes Treatment Amid High Pr - GuruFocus
VTVT Maintains Buy Rating -- Price Target Lowered to $42.00 by H - GuruFocus
vTv Therapeutics (NASDAQ:VTVT) Price Target Lowered to $42.00 at HC Wainwright - MarketBeat
VTv Therapeutics: Q2 Earnings Snapshot - marketscreener.com
vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
VTV THERAPEUTICS, INC. : H.C. WAINWRIGHT CUTS TARGET PRICE TO $42 FROM $45 - Bitget
vTv Therapeutics (VTVT) Holds Near $34.45 as Traders Eye $36.17 ResistanceSector ETF Flow - careplusvn.com
VTVT Q2'26 Earnings: revenue estimate is 333.33K USD - TradingView
vTv Therapeutics (VTVT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Precision Trading with Vtv Therapeutics Inc. (VTVT) Risk Zones - Stock Traders Daily
vTv Therapeutics (VTVT) Edges Down 1% to $32.35, Holding Gains Above Key SupportMotive Wave - dars.gov.et
vTv Therapeutics (NASDAQ:VTVT) Shares Pass Above Fifty Day Moving AverageHere's What Happened - marketbeat.com
vTv Therapeutics (VTVT) Slips 1%: Stock Holds Ground Between Key Support and ResistanceETF Inflow Streak - careplusvn.com
vTv Therapeutics Inc. Revenue Breakdown – NASDAQ:VTVT - tradingview.com
vTv Therapeutics Inc (VTVT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
vTv Therapeutics (VTVT): Millennium entities disclose 6.9% ownership of Class A shares - Stock Titan
vTv Therapeutics Grants Employees Options With 4-Year Vesting - Stock Titan
vTv Therapeutics Inc (VTVT) Cash Flow - TradingKey
Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):